(+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium

Date

Authors

Jimenez-Diaz, Maria Belen
Ebert, Daniel
Salinas, Yandira
Pradhan, Anupam
Lehane, Adele
Myrand-Lapierre, Marie-Eve
O'Loughlin, Kathleen
Shackleford, David
De Almeida, Mariana Justino
Carrillo, Angela

Journal Title

Journal ISSN

Volume Title

Publisher

National Academy of Sciences (USA)

Abstract

Drug discovery for malaria has been transformed in the last 5 years by the discovery of many new lead compounds identified by phenotypic screening. The process of developing these compounds as drug leads and studying the cellular responses they induce is

Description

Keywords

Citation

Source

PNAS - Proceedings of the National Academy of Sciences of the United States of America

Book Title

Entity type

Access Statement

Open Access

License Rights

Restricted until